LifeStance Health Group, Inc. $LFST Shares Sold by R Squared Ltd

R Squared Ltd reduced its stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) by 16.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,810 shares of the company’s stock after selling 3,240 shares during the quarter. R Squared Ltd’s holdings in LifeStance Health Group were worth $87,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of LFST. DekaBank Deutsche Girozentrale acquired a new stake in LifeStance Health Group during the 1st quarter worth $31,000. Park Edge Advisors LLC acquired a new stake in LifeStance Health Group during the 2nd quarter worth $52,000. Xponance Inc. acquired a new stake in LifeStance Health Group during the 1st quarter worth $69,000. Public Employees Retirement System of Ohio acquired a new stake in LifeStance Health Group during the 2nd quarter worth $70,000. Finally, Blair William & Co. IL acquired a new stake in LifeStance Health Group during the 2nd quarter worth $70,000. 85.50% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts recently commented on LFST shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of LifeStance Health Group in a research note on Saturday. Wall Street Zen lowered shares of LifeStance Health Group from a “buy” rating to a “hold” rating in a research note on Saturday, October 11th. BTIG Research assumed coverage on shares of LifeStance Health Group in a research note on Friday, July 25th. They issued a “buy” rating and a $8.00 price objective on the stock. UBS Group lifted their price objective on shares of LifeStance Health Group from $8.50 to $9.00 and gave the company a “buy” rating in a research note on Friday, August 8th. Finally, Zacks Research upgraded shares of LifeStance Health Group from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 7th. Two investment analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $8.50.

Insider Activity

In other news, Director Darren M. Black sold 8,407,643 shares of LifeStance Health Group stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $5.07, for a total value of $42,626,750.01. Following the sale, the director owned 33,524,715 shares of the company’s stock, valued at $169,970,305.05. The trade was a 20.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Silversmith Partners I. Gp, Llc sold 3,592,357 shares of the business’s stock in a transaction dated Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $18,213,249.99. Following the sale, the insider directly owned 14,324,197 shares in the company, valued at approximately $72,623,678.79. This represents a 20.05% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 20,407,643 shares of company stock valued at $103,466,750 over the last quarter. Corporate insiders own 3.20% of the company’s stock.

LifeStance Health Group Stock Up 1.2%

Shares of NASDAQ:LFST opened at $5.20 on Monday. The company has a market cap of $2.02 billion, a price-to-earnings ratio of -104.00 and a beta of 1.17. The firm’s 50-day simple moving average is $5.35 and its 200-day simple moving average is $5.37. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a fifty-two week low of $3.74 and a fifty-two week high of $8.61.

LifeStance Health Group (NASDAQ:LFST) last issued its earnings results on Thursday, August 7th. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.02. The business had revenue of $345.31 million for the quarter, compared to the consensus estimate of $345.05 million. LifeStance Health Group had a negative net margin of 1.23% and a negative return on equity of 1.11%. The business’s quarterly revenue was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.06) earnings per share. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, equities research analysts predict that LifeStance Health Group, Inc. will post -0.18 earnings per share for the current year.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.